1. Home
  2. MYFW vs LCTX Comparison

MYFW vs LCTX Comparison

Compare MYFW & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MYFW

First Western Financial Inc.

HOLD

Current Price

$30.92

Market Cap

312.1M

Sector

Finance

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

HOLD

Current Price

$1.00

Market Cap

255.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYFW
LCTX
Founded
2002
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
312.1M
255.4M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
MYFW
LCTX
Price
$30.92
$1.00
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
★ $27.00
$6.25
AVG Volume (30 Days)
37.2K
★ 1.1M
Earning Date
04-23-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 54.02
N/A
EPS
★ 1.20
N/A
Revenue
★ $96,914,000.00
$14,556,000.00
Revenue This Year
$20.48
$109.40
Revenue Next Year
$9.70
N/A
P/E Ratio
$25.48
★ N/A
Revenue Growth
7.60
★ 53.24
52 Week Low
$21.96
$0.91
52 Week High
$34.36
$2.09

Technical Indicators

Market Signals
Indicator
MYFW
LCTX
Relative Strength Index (RSI) 47.59 43.77
Support Level $30.06 N/A
Resistance Level $31.24 $1.18
Average True Range (ATR) 0.73 0.06
MACD 0.01 -0.01
Stochastic Oscillator 23.16 37.98

Price Performance

Historical Comparison
MYFW
LCTX

About MYFW First Western Financial Inc.

First Western Financial Inc is a financial holding company that provides a fully integrated suite of wealth management services on its private trust bank platform, which includes a comprehensive selection of deposit, loan, trust, wealth planning, and investment management products and services. The company has two operating segments; The Wealth Management segment consists of operations relative to the Company's fully integrated wealth management products and services, and The Mortgage segment consists of operations relative to the Company's residential mortgage service offerings. The bank derives its majority revenue from the wealth management segment.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: